Murchinson Ltd. Acquires 50,716 Shares of Amedisys, Inc. (NASDAQ:AMED)

Murchinson Ltd. boosted its holdings in shares of Amedisys, Inc. (NASDAQ:AMED) by 69.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 123,979 shares of the health services provider’s stock after buying an additional 50,716 shares during the period. Amedisys makes up about 1.7% of Murchinson Ltd.’s portfolio, making the stock its 10th largest position. Murchinson Ltd.’s holdings in Amedisys were worth $11,381,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of the business. Water Island Capital LLC raised its holdings in shares of Amedisys by 185.0% in the fourth quarter. Water Island Capital LLC now owns 710,697 shares of the health services provider’s stock valued at $67,559,000 after purchasing an additional 461,368 shares during the last quarter. Norges Bank purchased a new stake in shares of Amedisys in the fourth quarter valued at about $34,032,000. Highbridge Capital Management LLC raised its holdings in shares of Amedisys by 34.7% in the second quarter. Highbridge Capital Management LLC now owns 323,200 shares of the health services provider’s stock valued at $29,670,000 after purchasing an additional 83,200 shares during the last quarter. Flow State Investments L.P. raised its holdings in shares of Amedisys by 975.0% in the fourth quarter. Flow State Investments L.P. now owns 86,000 shares of the health services provider’s stock valued at $8,175,000 after purchasing an additional 78,000 shares during the last quarter. Finally, Park West Asset Management LLC raised its holdings in shares of Amedisys by 8.0% in the fourth quarter. Park West Asset Management LLC now owns 812,069 shares of the health services provider’s stock valued at $77,195,000 after purchasing an additional 60,350 shares during the last quarter. Institutional investors and hedge funds own 94.36% of the company’s stock.

Amedisys Price Performance

AMED opened at $96.63 on Friday. The firm has a market cap of $3.16 billion, a P/E ratio of -150.98, a PEG ratio of 1.90 and a beta of 0.78. The firm has a 50-day moving average of $97.61 and a 200 day moving average of $94.97. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. Amedisys, Inc. has a fifty-two week low of $89.55 and a fifty-two week high of $98.95.

Amedisys (NASDAQ:AMED) last issued its earnings results on Wednesday, July 24th. The health services provider reported $1.32 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.10. The firm had revenue of $591.19 million during the quarter, compared to analyst estimates of $579.34 million. Amedisys had a net margin of 4.02% and a return on equity of 12.39%. On average, research analysts expect that Amedisys, Inc. will post 4.66 EPS for the current year.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the stock. William Blair downgraded shares of Amedisys from an “outperform” rating to a “market perform” rating in a report on Monday, July 1st. Cantor Fitzgerald restated a “neutral” rating and set a $101.00 price target on shares of Amedisys in a research report on Thursday, July 25th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Amedisys from a “buy” rating to a “hold” rating and set a $101.00 price target for the company. in a research report on Monday, July 29th. Four analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $100.67.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.